- Report
- February 2018
- 302 Pages
Global
From €3909EUR$4,050USD£3,353GBP
- Report
- January 2024
- 112 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2024
- 73 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2024
- 113 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2020
- 40 Pages
United States
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Russia
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Germany
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
France
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2020
- 80 Pages
Africa
From €3663EUR$3,795USD£3,142GBP
- Report
- February 2024
- 176 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2024
- 206 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- September 2022
- 274 Pages
Global
From €5531EUR$5,730USD£4,744GBP
- Report
- July 2022
- 315 Pages
Global
From €5568EUR$5,769USD£4,776GBP
- Report
- February 2022
- 220 Pages
Global
From €5953EUR$6,168USD£5,107GBP
- Report
- May 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- May 2023
- 140 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- May 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- June 2018
- 368 Pages
The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more